Compare Inovio Pharmaceuticals Inc (INO) vs JetBlue Airways Corporation (JBLU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Inovio Pharmaceuticals Inc vs JetBlue Airways Corporation — how do they compare? Inovio Pharmaceuticals Inc trades at $0.91 (market cap $78.67M), while JetBlue Airways Corporation trades at $5.8 (market cap $2.18B). The key difference: JetBlue Airways Corporation is far larger — about 27.7× Inovio Pharmaceuticals Inc's market cap, and JetBlue Airways Corporation is trading nearer its 52-week high, Inovio Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.
| INO | JBLU | |
|---|---|---|
Market Cap | $78.67M | $2.18B |
Sector | Health | Industrials |
52-Week High | $2.87 | $6.46 |
52-Week Low | $0.66 | $4.03 |
Enterprise Value | $50.00M | $9.55B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Inovio Pharmaceuticals Inc
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Read more on INO →About JetBlue Airways Corporation
JetBlue Airways Corp is a low-cost airline that offers high-quality service, including assigned seating and in-flight entertainment. It carries over millions of customers with an average of more than 1,000 daily flights and served approximately 99 destinations in the United States, the Caribbean, and Latin America. The company currently operates Airbus A321, Airbus A320, and Embraer E190 aircraft types.
Read more on JBLU →
